Etifoxine

• CAT Number: I002661
• CAS Number: 21715-46-8
• Molecular Formula: C17H17ClN2O
• Molecular Weight: 300.80
• Purity: ≥95%
• Synonyms: 6-chloro-N-ethyl-4-methyl-4-phenyl-3,1-benzoxazin-2-amine
• Target: Neuronal Signaling
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IUPAC Name: 6-chloro-N-ethyl-4-methyl-4-phenyl-1H-3,1-benzoxazin-2-imine
• InChI: InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)
• InChIKey: IBYCYJFUEJQSMK-UHFFFAOYSA-N
• SMILES: CCN=C1NC2=C(C=C(C=C2)Cl)C(O1)(C)C3=CC=CC=C3

Etifoxine（Cat No.:I002661）is an anxiolytic and neuroprotective drug used primarily to treat anxiety disorders. It acts by modulating the GABAergic system, specifically by enhancing the effects of GABA (gamma-aminobutyric acid), a neurotransmitter that inhibits excessive neuronal activity. Unlike benzodiazepines, Etifoxine has a lower risk of dependence and sedation. It also has neuroprotective properties, as it promotes the production of neurotrophic factors that support brain health and neuronal survival. Etifoxine has been studied for its potential in treating both acute and chronic anxiety, with fewer side effects compared to traditional anxiolytics like benzodiazepines.